Portal:CPTAC

From WikiPathways

(Difference between revisions)
Jump to: navigation, search
(changed margins to give hallmark sections more room)
Line 9: Line 9:
}}
}}
-
<div style="float:left; width:68%"> <!-- This width add to the the margin below to equal 99%-->
+
<div style="float:left; width:73%"> <!-- This width add to the the margin below to equal 99%-->
{{{{FULLPAGENAME}}/box-normal
{{{{FULLPAGENAME}}/box-normal
Line 23: Line 23:
</div>
</div>
-
<div style="float:right; width:31%"> <!-- This margin should be right of the above -->
+
<div style="float:right; width:26%"> <!-- This margin should be right of the above -->
{{{{FULLPAGENAME}}/box-normal
{{{{FULLPAGENAME}}/box-normal

Revision as of 21:23, 4 October 2017

edit  

CPTAC Pathways

Welcome to the CPTAC Pathway Portal

This portal highlights pathway content relevant to the Clinical Proteomic Tumor Analysis Consortium (CPTAC).

The National Cancer Institute, part of the National Institutes of Health, announced the launch of a Clinical Proteomic Tumor Analysis Consortium in August 2011. CPTAC is a comprehensive and coordinated effort to accelerate the understanding of the molecular basis of cancer through the application of robust, quantitative, proteomic technologies and workflows. The overarching goal of CPTAC is to improve our ability to diagnose, treat and prevent cancer. To achieve this goal in a scientifically rigorous manner, the NCI launched CPTAC to systematically identify proteins that derive from alterations in cancer genomes and related biological processes, and provide this data with accompanying assays and protocols to the public.

The pathways included in this portal have been organized into classic cancer hallmark categories, based on the different biological capabilities acquired during the multistep development of human tumors. To read more, see Hallmarks of cancer: the next generation, Hanahan and Weinberg, Cell 2011.

edit  

Cancer Hallmark Categories

Sustaining proliferative signaling

Translation inhibitors in chronically activated PDGFRA cells (Homo sapiens)

Image does not exist
Translation inhibitors in chronically activated PDGFRA cells
Evading growth suppressors

Retinoblastoma gene in cancer (Homo sapiens)

Image does not exist
Retinoblastoma gene in cancer
Activating invasion and metastasis

MFAP5-mediated ovarian cancer cell motility and invasiveness (Homo sapiens)

Image does not exist
MFAP5-mediated ovarian cancer cell motility and invasiveness
Enabling replicative immortality

Wnt signaling (Homo sapiens)

Image does not exist
Wnt signaling
Inducing angiogenesis

Model for regulation of MSMP expression in cancer cells and its proangiogenic role in ovarian tumors (Homo sapiens)

Image does not exist
Model for regulation of MSMP expression in cancer cells and its proangiogenic role in ovarian tumors
Resisting cell death

Apoptosis (Homo sapiens)

Image does not exist
Apoptosis
Deregulating cellular energetics

Fatty acid beta-oxidation (Homo sapiens)

Image does not exist
Fatty acid beta-oxidation
Genome instability and mutation

ATM signaling (Homo sapiens)

Image does not exist
ATM signaling
Tumor promoting inflammation

IL1 signaling (Homo sapiens)

Image does not exist
IL1 signaling
Avoiding immune destruction

Altered glycosylation of MUC1 in tumor microenvironment (Homo sapiens)

Image does not exist
Altered glycosylation of MUC1 in tumor microenvironment
Therapeutics

Irinotecan pathway (Homo sapiens)

Image does not exist
Irinotecan pathway

edit  

Featured Pathways

edit  

Pathway Curation

On this page you see rotating displays of hallmark and featured pathways. Where did these pathways come from? They came from people like you! The CPTAC set of pathways can be edited, fixed and added to using the pathway drawing and annotation tools here at WikiPathways.

Getting Started

Resources

Curation projects

edit  

Useful Links

Personal tools